Characterization of parameters required for effective use of tamoxifen-regulated recombination. by Ben Buelow, Andrew M Scharenberg

Get full text

Structure/function analysis of PARP-1 in oxidative and nitrosative stress-induced monomeric ADPR formation. by Ben Buelow, Burak Uzunparmak, Marcia Paddock, Andrew M Scharenberg

Get full text

Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma by David M. Foureau, Manisha Bhutani, Myra Robinson, Fei Guo, Duy Pham, Ben Buelow, Nury Steuerwald, Katherine Rigby, Elise Tjaden, Marina Leonidas, Barry A. Paul, Shebli Atrash, Ami Ndiaye, James T. Symanowski, Peter M. Voorhees, Saad Z. Usmani

Get full text

S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY by Ryan Jacobs, Ranjit Nair, Seok-Goo Cho, Sumana Devata, Sameh Gaballa, Dok Hyun Yoon, Don Stevens, Jin Seok Kim, Nirav N Shah, Denise Marie Brennan, Jason Law, Robin Lesley, Rob Chen, Alessandra Forcina, Ben Buelow, Jing-Zhou Hou

Get full text

A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer by Brian C. Avanzino, Kirthana Prabhakar, Pranjali Dalvi, Sharon Hartstein, Hannes Kehm, Aarti Balasubramani, Andrew A. Boudreau, Ben Buelow, Karen Chang, Laura M. Davison, Suhasini Iyer, Vidyut Kalwit, Kristin Lewis Wilson, Harbani K. Malik-Chaudhry, Will Pierson, Geovanni Pineda, Udaya S. Rangaswamy, Sowmya Saiganesh, Ute Schellenberger, Harshad S. Ugamraj, Rodolfovan D. Yabut, Roland Buelow, Jocelyn Chapman, Nathan D. Trinklein, Katherine E. Harris

Get full text